Moreover, considering our results and the potential of NSAIDs to target multiple glycolysis-related proteins, it would be interesting to test these drugs in tumours where Ldha inhibition has proven successful in preclinical studies, such as pancreatic and lung cancers. This evidence concerns the gene LDHA and lung carcinoma.